ADAGE CAPITAL PARTNERS GP L.L.C. 13D and 13G filings for Marinus Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-02-07 07:25 am Sale | 2023-12-31 | 13G | Marinus Pharmaceuticals, Inc. MRNS | ADAGE CAPITAL PARTNERS GP L.L.C. | 2,581,250 4.730% | -175,000 (-6.35%) | Filing |
| 2023-07-06 4:20 pm Purchase | 2023-06-26 | 13G | Marinus Pharmaceuticals, Inc. MRNS | ADAGE CAPITAL PARTNERS GP L.L.C. | 2,756,250 5.450% | 1,293,750 (+88.46%) | Filing |
| 2021-02-11 08:16 am Purchase | 2020-12-31 | 13G | Marinus Pharmaceuticals, Inc. MRNS | ADAGE CAPITAL PARTNERS GP L.L.C. | 1,462,500 4.110% | 1,462,500 (New Position) | Filing |